REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 83 filers reported holding REVANCE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86 | +4.9% | 7,525 | +133.3% | 0.00% | – |
| Q2 2023 | $82 | -39.3% | 3,225 | -23.1% | 0.00% | – |
| Q1 2023 | $135 | +73.1% | 4,196 | 0.0% | 0.00% | – |
| Q4 2022 | $78 | -99.9% | 4,196 | +26.3% | 0.00% | – |
| Q3 2022 | $90,000 | +95.7% | 3,322 | 0.0% | 0.00% | – |
| Q2 2022 | $46,000 | -33.3% | 3,322 | 0.0% | 0.00% | – |
| Q1 2022 | $69,000 | +27.8% | 3,322 | 0.0% | 0.00% | – |
| Q4 2021 | $54,000 | -41.9% | 3,322 | 0.0% | 0.00% | – |
| Q3 2021 | $93,000 | -5.1% | 3,322 | 0.0% | 0.00% | – |
| Q2 2021 | $98,000 | +6.5% | 3,322 | 0.0% | 0.00% | – |
| Q1 2021 | $92,000 | -31.9% | 3,322 | -30.5% | 0.00% | – |
| Q4 2020 | $135,000 | +95.7% | 4,778 | +73.7% | 0.00% | – |
| Q3 2020 | $69,000 | +3.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2020 | $67,000 | +63.4% | 2,750 | 0.0% | 0.00% | – |
| Q1 2020 | $41,000 | -6.8% | 2,750 | 0.0% | 0.00% | – |
| Q4 2019 | $44,000 | -34.3% | 2,750 | -46.9% | 0.00% | – |
| Q2 2019 | $67,000 | -17.3% | 5,183 | 0.0% | 0.00% | – |
| Q1 2019 | $81,000 | +62.0% | 5,183 | +103.0% | 0.00% | – |
| Q4 2018 | $50,000 | -20.6% | 2,553 | 0.0% | 0.00% | – |
| Q3 2018 | $63,000 | -10.0% | 2,553 | 0.0% | 0.00% | – |
| Q2 2018 | $70,000 | -11.4% | 2,553 | 0.0% | 0.00% | – |
| Q1 2018 | $79,000 | -13.2% | 2,553 | 0.0% | 0.00% | – |
| Q4 2017 | $91,000 | +31.9% | 2,553 | 0.0% | 0.00% | – |
| Q3 2017 | $69,000 | +3.0% | 2,553 | 0.0% | 0.00% | – |
| Q2 2017 | $67,000 | +26.4% | 2,553 | 0.0% | 0.00% | – |
| Q1 2017 | $53,000 | 0.0% | 2,553 | 0.0% | 0.00% | – |
| Q4 2016 | $53,000 | -35.4% | 2,553 | -50.0% | 0.00% | – |
| Q3 2016 | $82,000 | +134.3% | 5,106 | +100.0% | 0.00% | – |
| Q2 2016 | $35,000 | -22.2% | 2,553 | 0.0% | 0.00% | – |
| Q1 2016 | $45,000 | -48.3% | 2,553 | 0.0% | 0.00% | – |
| Q4 2015 | $87,000 | – | 2,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |